Akzo Nobel to Develop Avian Flu Vaccine
Posted on: Thursday, 31 August 2006, 09:00 CDT
Dutch chemicals company Akzo Nobel, through its human vaccines business, Nobilon International, has signed an agreement with the Center for Disease Control and Prevention (CDC), to develop an avian flu vaccine.
The vaccine will be specifically developed to be a live vaccine for the H5N1 strain of the virus. The World Health Organization commented that a live vaccine would offer better and broader protection in the event of a pandemic.
Nobilon said that one of its aims would be to increase the speed and efficiency of production. This would enable them to create a sufficient supply of the vaccine, usually a problem for many developers of pandemic vaccines.
The cooperative research will be carried out over two years at Boxmeer in the Netherlands and Atlanta in the US.
A live attenuated influenza vaccine has been shown to have a number of advantages. It can trigger a broader immune response than inactivated influenza vaccines in children, as well as allowing for a single dose of a smaller amount of vaccine to provide meaningful protection, compared with currently available inactivated vaccines.
Source: Datamonitor
Related Articles
- Improving Vaccine Efficacy For The Elderly
- Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and Metabolic Syndrome
- GSK Receives Favorable Recommendation By FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
- Analysis: Live Flu Vaccine Protects Kids
- Merck Updates Prescribing Information for ROTATEQ(R), the Company's Vaccine to Help Prevent Rotavirus Gastroenteritis in Infants and Children
- FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
- Bleach May Help to Beat Cancer
- CDC Advisory Committee on Immunization Practices Votes to Recommend Inclusion of ROTATEQ(R) in the Vaccines for Children (VFC) Program
- FDA Approves Merck's ROTATEQ(R), The Only Vaccine in the U.S. To Prevent Rotavirus Gastroenteritis
- Pet Owners Must Not Become Complacent About Vaccinations
 |
 |
User Comments (0)
RSS Feeds